Evidence map›Paper›PMID 42754698›Full record

ArticleNature2026

Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.

Prasenjit Dey, Joelle Baddour, Florian Muller, Chia Chin Wu, Huamin Wang, Wen-Ting Liao, Zangdao Lan, Alina Chen, Tony Gutschner, Yaan Kang and 15 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Prasenjit Dey *Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Joelle Baddour *Department of Chemical and Biomolecular Engineering, Department of Bioengineering, Rice University, Houston, Texas, USA.
Florian MullerDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chia Chin WuDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Huamin WangDepartment of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wen-Ting LiaoDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zangdao LanDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Alina ChenDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tony GutschnerDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yaan KangDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jason FlemingDepartment of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nikunj SataniDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Di ZhaoDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abhinav AchrejaDepartment of Chemical and Biomolecular Engineering, Department of Bioengineering, Rice University, Houston, Texas, USA.
Lifeng YangDepartment of Chemical and Biomolecular Engineering, Department of Bioengineering, Rice University, Houston, Texas, USA.
Jiyoon LeeDepartment of Chemical and Biomolecular Engineering, Department of Bioengineering, Rice University, Houston, Texas, USA.
Edward ChangDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Giannicola GenoveseDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Andrea VialeDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Haoqiang YingDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Giulio DraettaDepartment of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Anirban MaitraDepartment of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Y Alan WangDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. yalanwang@mdanderson.org.
Deepak NagrathDepartment of Chemical and Biomolecular Engineering, Department of Bioengineering, Rice University, Houston, Texas, USA. deepak.nagrath@rice.edu.
Ronald A DePinhoDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. rdepinho@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42754698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.